Cell Signaling Technology and LI-COR to Validate, Co-Market Cellular Assays | GenomeWeb

NEW YORK, June 1 (GenomeWeb News) - Cell Signaling Technology and LI-COR Biosciences said today that they have signed a joint marketing and validation agreement for CST's antibody reagents used with LI-COR's cellular assays.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.